Abstract 2927: CS2011: A novel bispecific antibody targeting EGFR and HER3 that demonstrates promising antitumor activity in preclinical evaluation

Chuan Wang(Ascepion Pharmaceuticals (China)), Jianxin Yang(Ascepion Pharmaceuticals (China)), Jingyu Sun(Soochow University), Fei Ma(Shenzhen University), Ning Zhang(Ascepion Pharmaceuticals (China)), Xuelian Liu(Ascepion Pharmaceuticals (China)), Yi Sun(Ascepion Pharmaceuticals (China)), Yongli Yang(Southwest Forestry University), Yongwang Li(Tianjin University), Xinling Zhang(Dalian Maritime University), Mengyao Zhu(Ascepion Pharmaceuticals (China))
Cancer Research
April 21, 2025
Cited by 1


Related Papers